Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Tonix Pharmaceuticals Awarded Up To $34M OTA By U.S. Defense Threat Reduction Agency To Develop Broad-Spectrum Antiviral Agents; Focus On TNX-4200 Program For Military Medical Readiness In Biological Threat Environments; Supports Preclinical Evaluation And Phase 1 Clinical Study

Author: Benzinga Newsdesk | July 29, 2024 09:04am

Posted In: TNXP